HOME >> MEDICINE >> NEWS
New TB test scoops top prize at Medical Futures competition

An inexpensive and rapid test for tuberculosis (TB) which could be used in developing countries has won first place in the Best Innovation to Improve Global Healthcare category of the Medical Futures Innovation Awards. It also scooped the overall prize at the awards ceremony held last week in London.

The test, known as MODS (Microscopic Observation Drug Susceptible Assay) is able to confirm the presence of TB from sputum samples in one week on average, taking one third to one quarter of the time of a standard TB test. At the same time, the new test is able to spot if the TB is drug resistant which is five to ten times faster than existing tests. The test costs $2 to perform compared with around $30 to $40 for a standard test.

Dr David Moore, from Imperial College London, and the winner of the Award said: "This test can be carried out using cheap and readily available tools and requires relatively little training or expertise. This is particularly important in developing countries which may not have the infrastructure we take for granted in the developed world."

Each year around 8 million new cases of TB are diagnosed, and 1.7 million people die from TB, often as a result of delayed diagnosis and through not being able to spot if the TB is drug resistant.

Working with colleagues from Peru's National TB Programme, the Universidad Peruana Cayetano Heredia, AB PRISMA, and John Hopkins Bloomberg School of Public Health, the team realised many TB patients were dying unnecessarily largely due to an inability to cheaply and quickly diagnose TB. They have now completed proof of principle studies, evaluated the test in large-scale field trials, and are now looking at strategies for implementation and roll-out to optimize impact and cost-effectiveness.

Professor Jon Friedland, from Imperial College London, who helped develop the test, added: "TB is a major cause of mortality in the developing world, and eradicating it has been made d
'"/>

Contact: Tony Stephenson
at.stephenson@imperial.ac.uk
44-207-594-6712
Imperial College London
7-Nov-2005


Page: 1 2

Related medicine news :

1. Polish journalist scoops first prize in prestigious European award
2. Melbourne trailblazer scoops medical research award
3. MIT graduate student wins $30,000 Lemelson-MIT student prize for life-saving inventions
4. Top NIH prize goes to three pioneering Stanford scientists
5. Karolinska Institutet prize for innovations in medical pedagogics
6. UCI epilepsy researcher receives nations top neuroscience prize
7. Daniel Zheng wins SIAMs first prize at INTEL-ISEF
8. Penn Scientist receives first annual prize for scientific contributions to womens health
9. Karen Duff receives prestigious prize for Alzheimers research
10. MRI pioneer wins national physics prize
11. Cancer researcher Susan Horwitz wins Alpert prize for Taxol work

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New test scoops top prize Medical Futures competition

(Date:3/4/2015)... New York (PRWEB) March 04, 2015 ... ) that allege the statin drug caused patients to ... the U.S. District Court, District of South Carolina. According ... be convened on March 26, 2015 at 10:00 a.m. ... directed to submit a Joint Status report to the ...
(Date:3/4/2015)... 04, 2015 FDA’s New Inspection Approach:, ... Webinar**, March 24, 2015 — 1:30 p.m. – 3:00 ... know within four hours of an inspection whether a ... on their “good” list, they’ll merely ask for reassurance ... is on the “bad” list, the manufacturer must get ...
(Date:3/4/2015)... 04, 2015 The ability of ... density assessment and help improve breast cancer risk ... accepted for presentation at the European Congress of ... abstracts - eight posters and 2 session presentations ... breast density and quantitative breast imaging software tools ...
(Date:3/4/2015)... March 04, 2015 With the growing influence ... lives of our teens and young adults, combined with the ... and confusing to try to keep up with what kids ... or trend is replaced on a daily basis. , The ... and the slang that is used to discreetly talk about ...
(Date:3/4/2015)... York (PRWEB) March 04, 2015 More ... the cardiovascular risks potentially associated with low testosterone treatments ... (FDA) announced that it will now require manufacturers to ... their risk for heart attacks and strokes. In a ... the agency also stated that it was requiring testosterone ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4
(Date:3/4/2015)... , March 4, 2015  NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank , Chief Executive ... in Miami, FL on Wednesday, March ... webcast of the event will be made available at ... About NxStage NxStage Medical, Inc. (Nasdaq: ...
(Date:3/4/2015)... AUSTIN, Texas , March 4, 2015 /PRNewswire/ ... Phase II pilot study in patients with moderate ... JAMA Dermatology. The open-label Phase II trial evaluated ... Human™ monoclonal antibody that targets interleukin-1 alpha (IL-1a). ... and inflammatory cells present in skin lesions. The ...
(Date:3/4/2015)...  Results of the recent study, Results From ... Intra-Operative Positive Margin Detection , were presented as part ... Annual Miami Breast Cancer Conference last week. ... , MD, FACS, Professor of Surgery at the Sackler ... analysis of MarginProbe,s efficiency and accuracy when used consecutively ...
Breaking Medicine Technology:NxStage to Present at the Barclays Capital Global Healthcare Conference 2XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2
Cached News: